Ji Hoon Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ji Hoon Choi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Woong Park
College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea
3 shared publications - Dong-Wook Kim
College of Pharmacy, Wonkwang University, Iksan, Republic of Korea
2 shared publications - Je Hwa Yoo
Department of Pharmacy, College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
2 shared publications - Ji-Hyun Kang
School of Pharmacy, Jeonbuk National University, Jeonju 54896, Republic of Korea
2 shared publications - Jin-Hyuk Jeong
Department of Pharmacy, Chungbuk National University, Cheongju 28644, Republic of Korea
2 shared publications - Dong-Won Oh
Korea United Pharm R&D Center, Sejong, Republic of Korea
1 shared publication
Latest Publications
- 31 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 56 (1) , 79-95
Mechanistic pharmacokinetic models for inhaled drug development: pulmonary physiological and structural characteristics and modeling approaches
- 31 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 56 (1) , 79-95
Mechanistic pharmacokinetic models for inhaled drug development: pulmonary physiological and structural characteristics and modeling approaches
- 25 November 2024
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 55 (3) , 375-396
Recent quality by design approaches for process optimization and quality enhancement of dry powder inhalers
- 25 November 2024
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 55 (3) , 375-396
Recent quality by design approaches for process optimization and quality enhancement of dry powder inhalers
- Open Access
- 26 October 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1374
NIR-Guided Coating Optimization of Omega-3 Fatty Acid Mini Soft Capsules with Pitavastatin and Ezetimibe
Background: This study aimed to optimize the coating process of Omega-3 fatty acid (OM3-FA) mini soft capsules containing the active pharmaceutical ingredients (APIs) pitavastatin and ezetimibe using near-infrared (NIR) spectroscopy for in-process monitoring. Cardiovascular disease treatments benefit from combining OM3-FA with lipid-lowering agents, but formulating such combinations in mini soft capsules presents challenges in maintaining stability and mechanical integrity. Methods: The coating process was developed using a pan coater and real-time NIR monitoring to ensure uniformity and quality. NIR spectroscopy enabled precise control of coating thickness, ensuring consistent drug distribution across the capsule surface. Results: The optimized process minimized OM3-FA oxidation and preserved the mechanical integrity of the capsules, as confirmed by texture analysis and in-vitro dissolution testing. This integration of NIR spectroscopy as a process analytical technology (PAT) significantly improved coating quality control, resulting in a stable and effective combination therapy for pitavastatin and ezetimibe in a mini soft capsule form. Conclusion: This approach offers an efficient solution for enhancing patient adherence in cardiovascular disease management. The application of NIR spectroscopy for real-time monitoring highlights its broader significance in pharmaceutical manufacturing, where it can serve as a versatile tool for ensuring product quality and optimizing production efficiency in diverse formulation processes. By incorporating NIR-based PAT, manufacturers can not only achieve product-specific improvements but also establish a foundation for continuous manufacturing and automated quality assurance systems, ultimately contributing to a more streamlined and robust production environment.
- 26 October 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1374
Open AccessNIR-Guided Coating Optimization of Omega-3 Fatty Acid Mini Soft Capsules with Pitavastatin and Ezetimibe
Background: This study aimed to optimize the coating process of Omega-3 fatty acid (OM3-FA) mini soft capsules containing the active pharmaceutical ingredients (APIs) pitavastatin and ezetimibe using near-infrared (NIR) spectroscopy for in-process monitoring. Cardiovascular disease treatments benefit from combining OM3-FA with lipid-lowering agents, but formulating such combinations in mini soft capsules presents challenges in maintaining stability and mechanical integrity. Methods: The coating process was developed using a pan coater and real-time NIR monitoring to ensure uniformity and quality. NIR spectroscopy enabled precise control of coating thickness, ensuring consistent drug distribution across the capsule surface. Results: The optimized process minimized OM3-FA oxidation and preserved the mechanical integrity of the capsules, as confirmed by texture analysis and in-vitro dissolution testing. This integration of NIR spectroscopy as a process analytical technology (PAT) significantly improved coating quality control, resulting in a stable and effective combination therapy for pitavastatin and ezetimibe in a mini soft capsule form. Conclusion: This approach offers an efficient solution for enhancing patient adherence in cardiovascular disease management. The application of NIR spectroscopy for real-time monitoring highlights its broader significance in pharmaceutical manufacturing, where it can serve as a versatile tool for ensuring product quality and optimizing production efficiency in diverse formulation processes. By incorporating NIR-based PAT, manufacturers can not only achieve product-specific improvements but also establish a foundation for continuous manufacturing and automated quality assurance systems, ultimately contributing to a more streamlined and robust production environment.